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Introduction 
Aim of the Study 
Results 
The study was carried out in Portugal in a sample of 46 
subjects exposed occupationally to cytostatics and 46 subjects 
without any occupational exposition.  
Blood samples were taken and used to measure genetic 
instability biomarkers represented by DNA damage breaks and 
oxidative stress. The evaluation of genotoxic effects was 
conducted by applying two techniques: cytokinesis-blocked 
micronucleus assay (CBMN) and comet assay in peripheral 
blood lymphocytes. 
CBMN allowed to measure DNA damage by quantifying 
micronucleus (MN), nucleoplasmic bridges (NPB) and nuclear 
Buds (NBUD). Comet assay measured DNA breaks (% DNA in 
tail) and oxidative DNA damage (FPG). A food-frequency 
questionnaire was fulfilled, and the selenium intake calculated 
using the FREQUAN dietary analysis program.  
 
 
Methodology 
It was not found any statistical significant association between the genotoxicity biomarkers studied and selenium in each group. For 
both groups, the increase of selenium intake was related with the decrease of genomic instability, however without reaching statistical 
significance. 
Current dietary recommendations do not consider the concept of genome stability which is of concern because damage to the genome 
has been linked to the origin and progression of many diseases and is the most fundamental pathology. 
Table 2 - Spearman correlations between MN, NPB, NBUD, % DNA in tail and oxidative DNA damage (FPG) 
and selenium item in the exposed (A) and the control (B) groups. No significant correlations were signaled. 
Selenium functions as a co-factor for the reduction of antioxidant 
enzymes and is an important component of antioxidant enzymes.  
Dietary selenium significantly inhibits the induction of skin, liver, 
colon, and mammary tumours in experimental animals by a 
number of different carcinogens, as well as the induction of 
mammary tumours by viruses.  
Selenium shows a “U” shaped curve for functionality, whereby too 
little is as damaging as too much. At optimal levels, selenium may 
protect against the formation of DNA adducts, DNA or 
chromosome breakage, chromosome gain or loss, mitochondrial 
DNA, and telomere length and function.  
Investigate the relation between selenium and genotoxic effects in a 
human biomonitoring study applied to occupational health.  
Parameters Groups 
Mean± Std. Deviation 
(daily nutrient 
intake) 
  
Dietary References Intakes 
(Food and Nutrition Board, Institute 
of Medicine, National Academies) 
d= day 
  
Selenium 
Exposed 
131.51±9.34 
  
  
45 µg/d 
Controls 
138.67±8.58 
  
Table 1 –Dietary parameters of selenium measured by FFQ (mean intake per day ± standard deviation)  and 
respective dietary reference intakes.  
Selenium item was measured by Food Frequency Questionnaire (FFQ). 
The quantification of the dietary parameters for this is shown in Table 
1.  
  Selenium 
MN lymp -0.053 
NPB -0.037 
NBUD -0.148 
% DNA TAIL 0.073 
FPG -0.069 
  Selenium 
MN BN -0.096 
NPB -0.143 
NBUD -0.063 
% DNA TAIL -0.222 
FPG 0.074 
A – Exposed  
B – Non-Exposed  
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